$24 million in grants to help end HIV epidemic across the globe

pharmafile | March 30, 2022 | News story | Research and Development  

Gilead Sciences announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education, and support local communities most impacted by the HIV epidemic and COVID-19 epidemic.

The ‘Zeroing in: Ending the HIV Epidemic program’ will support 116 organisations in 41 countries. The funding recipients will focus on advancing at least one of three focus areas: ‘Comprehensive HIV Innovation’, ‘Digital Health Innovation’, and ‘Community Outreach and Education’.

“This funding will empower very isolated families to manage their HIV at home and to quickly access medical care when additional support is needed, without creating undue financial burdens on families that are experiencing significant hardship. It will also help us combat the devastating stigma that exists around HIV throughout Nepal. This will make it easier to access care, maintain community ties, and keep safe and healthy,” said Crystal Anderson, Grants and Donor Communications Manager, Nepal Youth Foundation.

In local communities, Zeroing In organisations will prioritise populations most affected by the HIV epidemic, including in projects from local organisations collaborating to end the HIV epidemic in their respective cities, states, countries, or regions.

“Through Gilead Sciences’ Zeroing In program, a collective of 10 migrant-led frontline organisations across Europe have the opportunity to work collectively for the first time to address HIV knowledge, testing and treatment barriers amongst migrant communities,” said Denis Onyango, Programmes Director, Africa Advocacy Foundation.

Through the digital health area of the program, strategies will address the health literacy divide in accessing digital health services, support digital access in rural areas, and support digital health education for those with barriers of access including language barriers, the aging, and stigmatised populations.

“Through this funding, we will be able to increase community awareness of HIV and PrEP to marginalised communities across Mississippi, through trained community health workers. We plan to address HIV stigma, and structural and institutional barriers associated with HIV care in Mississippi. It is only through support from organisations like Gilead that we will truly be able to end the HIV epidemic,” said Dr Christopher Roby, Chief Operations Officer, Community Health Centre Association of Mississippi.

Ana Ovey

Related Content

No items found

Latest content